why choose us

First received: May 06, 2023

Clinical Trial: Nitric Oxide Releasing Solution (NORS) For The Treatment Of Human Papillomavirus(HPV) Verrucae Plantaris (Plantar Warts)

Study Status: Completed

Recruit Status: RECRUITING

Condition: Verruca Plantaris

Study Type: INTERVENTIONAL


Official Title: Phase 2a Multicenter, Randomized, Double-Blinded, Placebo-Controlled Clinical Trial To Evaluate The Safety And Efficacy Of Topical Nitric Oxide Releasing Solution For The Treatment Of Human Papillomav

Brief Summary: A phase 2a multicenter, randomized, double-blinded, placebo-controlled clinical trial to evaluate the safety and efficacy of topical nitric oxide releasing solution (NORS) for the treatment of human papillomavirus (HPV) caused verrucae plantaris (plantar warts).Participants will be treated over a 21 day period with a final evaluation on Day 35.They will be separated into 3 treatment groups (placebo, 1x and 2x dose).Participants will be evaluated for change in wart size, wart clearance, and HPV genotype.

Read more